Kategorien
Index

Nifty Pharma

SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse
INR
  • Nifty Pharma
    Börse NSI
    INR
  • INR

66 News & Informationen zur Nifty Pharma Aktie

  • Sensex, Nifty close marginally lower from record high on profit-taking
    thehindubusinessline.com

  • How broadening of Nifty Pharma Index will impact investors
    livemint.com

    How broadening of Nifty Pharma Index will impact investors

    One major reorganization happened in the Nifty Pharma Index, which will now have 20 companies as its constituents instead of the 10 at present

  • Taper or no taper, market set to hit an intermediate top: Here are your cues
    economictimes.indiatimes.com

    Taper or no taper, market set to hit an intermediate top: Here are your cues

    Even in the absence of so called ‘taper tantrum, if we look at the global scenario in isolation, markets seem to have developed froth with bloated valuations, thereby warranting a major correction as a measure of self-check and a balancing act, if they have to remain in a sustainable bull market for a longer period.

  • After new highs, benchmarks surrender gains
    thehindubusinessline.com

  • REITs, InvITs to be included in Nifty indices from Sep 30
    economictimes.indiatimes.com

    REITs, InvITs to be included in Nifty indices from Sep 30

    In a statement on Monday, the exchange said all equity shares, REITs and InvITs that are traded (listed and traded and not listed but permitted to trade) at the NSE are eligible for inclusion in the Nifty indices.

  • REITs, InvITs to be included in Nifty indices from September 30
    moneycontrol.com

    REITs, InvITs to be included in Nifty indices from September 30

    REITs and Infrastructure Investment Trusts (InvITs) are relatively new investment instruments in the Indian context but extremely popular in global markets.

  • 4 Highest Piotroski Score Stocks In Nifty 500
    goodreturns.in

    4 Highest Piotroski Score Stocks In Nifty 500

    The Piotroski Score estimates the financial strength of a company based on nine indicators: ROA, Change in ROA, CFO, Leverage, Change in current ratio, Change in Gross Margin, Assets Turnover Ratio, Share Issued, and Accruals. It is considered a solid investment if the score adds up to 8 or 9. If the total is 0 or 2, the stock is considered a poor investment.

  • Sensex falls 300 points, Nifty ends below 16,500 on selling across counters
    thehindubusinessline.com

    Sensex falls 300 points, Nifty ends below 16,500 on selling across counters

    Metal index slumps over 6%, while FMCG stocks remain firm

  • Sensex down 325 points intraday, Nifty below 16,500
    thehindubusinessline.com

  • Sensex closes below 56,000; Nifty below 16,600
    thehindubusinessline.com

    Sensex closes below 56,000; Nifty below 16,600

    Benchmark indices erase gains, dragged by heavyweight financials, metals

  • Warren Buffett cuts stakes in pharma stocks, exits Biogen; Nifty Pharma tanks 4% in 1 month
    financialexpress.com

    Warren Buffett cuts stakes in pharma stocks, exits Biogen; Nifty Pharma tanks 4% in 1 month

    Warren Buffett's Berkshire Hathaway slashed stakes in several pharmaceutical companies such as Abbvie Inc, Bristol-Myers Squibb Co and Merck & Co. in the second quarter of FY21.

  • Share Market Live: Sensex, Nifty Open At New Highs As HDFC Bank Jumps On RBI Easing
    bloombergquint.com

    Share Market Live: Sensex, Nifty Open At New Highs As HDFC Bank Jumps On RBI Easing

    Catch all live updates on share prices, index moves, corporate announcements and more from Indian stock markets today.

  • Stock market update: Nifty Pharma index advances 0.54%
    economictimes.indiatimes.com

    Stock market update: Nifty Pharma index advances 0.54%

    The Nifty Pharma index closed 0.54 per cent up at 14041.25.

  • Fag-end buying in IT, FMCG stocks lift Sensex by 210 pts; Nifty settles above 16,600 for first time
    economictimes.indiatimes.com

    Fag-end buying in IT, FMCG stocks lift Sensex by 210 pts; Nifty settles above 16,600 for first time

    Buying was seen in IT and FMCG counters, while broader market stocks continued to reel under pressure.

  • Fiem Industries : Indian shares gain on pharma, tech stocks boost
    marketscreener.com

    Fiem Industries : Indian shares gain on pharma, tech stocks boost

    Indian shares rose on Tuesday, after closing at record highs in the previous session, as gains in pharma and technology stocks helped investors look past losses in banks and rising global cases of… | August 17, 2021

  • Bull run in drug stocks face first hurdle as old headache returns
    economictimes.indiatimes.com

    Bull run in drug stocks face first hurdle as old headache returns

    While producers of bulk drugs and contract manufacturers have done well for themselves so far, the rally in shares of generic drugs manufacturers is now facing its first hurdle.

  • Benchmark indices trade in the green after scaling new peaks, led by IT
    thehindubusinessline.com

  • Stock market update: Nifty Pharma index falls 1.46%
    economictimes.indiatimes.com

    Stock market update: Nifty Pharma index falls 1.46%

    The Nifty Pharma index closed 1.46 per cent down at 14291.15.

  • Sensex down 194 pts intraday, Nifty below 16,300 amid profit-booking
    thehindubusinessline.com

  • Stock market update: Nifty Pharma index falls 0.21%
    economictimes.indiatimes.com

    Stock market update: Nifty Pharma index falls 0.21%

    The Nifty Pharma index closed 0.21 per cent down at 14502.9.

  • Sensex up 125 at closing, Nifty above 16,200
    thehindubusinessline.com

  • Stock market update: Nifty Pharma index falls 0.59% in an upbeat market
    economictimes.indiatimes.com

    Stock market update: Nifty Pharma index falls 0.59% in an upbeat market

    The Nifty Pharma index was trading 0.59 per cent down at 14431.75.

  • Benchmark indices trade lower amid volatility post RBI meeting outcome
    thehindubusinessline.com

    Benchmark indices trade lower amid volatility post RBI meeting outcome

    Sensex down 185 pts, Nifty below 16,300 as financials, pharma and realty face pressure

  • Nifty scales 16K mark for first time, Sensex hits record high: Key factors that fuelled the rally
    businesstoday.in

    Nifty scales 16K mark for first time, Sensex hits record high: Key factors that fuelled the rally

    Nifty scaled the key 16,000 mark today as across the board buying despite subdues global cues lifted market sentiment. The 50-stock index zoomed 140 points to a record high of 16,025, signaling the underlying bullish sentiment despite rising coronavirus cases and fears of high inflation.

  • Taking Stock: Sensex, Nifty end marginally lower amid volatility; pharma outshines
    moneycontrol.com

    Taking Stock: Sensex, Nifty end marginally lower amid volatility; pharma outshines

    Among sectors, the Nifty pharma index added 3.6 percent, while the auto index rose nearly a percent. However, some selling was seen in the metal and financial names.

  • Stock market update: Nifty Pharma index falls 0.32%
    economictimes.indiatimes.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Dir gefallen die Informationen zu Nifty Pharma?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF-Sparplan im Quartal bleibt dein Depot für Immer kostenfrei:

Zum Angebot

Dir gefallen die Informationen zu Nifty Pharma?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen ETF-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Nifty Pharma?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos ETFs zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic